000 01430 a2200385 4500
005 20250517174725.0
264 0 _c20171121
008 201711s 0 0 eng d
022 _a1879-0852
024 7 _a10.1016/j.ejca.2017.08.023
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aTella, Sri Harsha
245 0 0 _aHIF-2alpha: Achilles' heel of pseudohypoxic subtype paraganglioma and other related conditions.
_h[electronic resource]
260 _bEuropean journal of cancer (Oxford, England : 1990)
_c11 2017
300 _a1-4 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAntineoplastic Agents
_xtherapeutic use
650 0 4 _aBasic Helix-Loop-Helix Transcription Factors
_xantagonists & inhibitors
650 0 4 _aCarcinoma, Renal Cell
_xdrug therapy
650 0 4 _aDrug Design
650 0 4 _aHumans
650 0 4 _aIndans
_xtherapeutic use
650 0 4 _aKidney Neoplasms
_xdrug therapy
650 0 4 _aMolecular Targeted Therapy
650 0 4 _aMutation
650 0 4 _aParaganglioma
_xdrug therapy
650 0 4 _aSignal Transduction
650 0 4 _aSulfones
_xtherapeutic use
650 0 4 _aTumor Hypoxia
650 0 4 _aTumor Microenvironment
700 1 _aTaïeb, David
700 1 _aPacak, Karel
773 0 _tEuropean journal of cancer (Oxford, England : 1990)
_gvol. 86
_gp. 1-4
856 4 0 _uhttps://doi.org/10.1016/j.ejca.2017.08.023
_zAvailable from publisher's website
999 _c27600249
_d27600249